PHARMAZEUTISCHE ENTWICKLUNG

European patent · EP4003293 · In force

Register entry

Publication number
EP4003293
Application number
EP20751254
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 28, 2020
Published
Jun 1, 2022
Granted
Jun 4, 2025
Protection ends at the latest
Jul 27, 2040
Next annual fee due
Jul 31, 2026
IPC classes
A61K 9/00 (2006.01)
A61K 9/19 (2006.01)
A61K 31/7072 (2006.01)
A61K 38/12 (2006.01)
Priority
GB 201910787 29.07.2019
PCT application
PCT/GB2020/051810 28.07.2020
PCT publication
WO2021/019234 04.02.2021
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 16, 2026

    Change

    Published in Swissreg on 16.04.2026

  2. Aug 8, 2025

    Change

    Published in Swissreg on 08.08.2025

  3. Aug 4, 2025

    Agent entered

    Representative
    HGF GmbH, OBC Suisse AG, Aeschengraben 29, 4051 Basel

    Published in Swissreg on 04.08.2025

  4. Jun 4, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 04.06.2025

Parties

Holder

Helperby Therapeutics Limited

66 Lincoln's Inn Fields, London, Greater London WC2A 3LH, GB

Agent

HGF GmbH

HGF GmbH OBC Suisse AG

Aeschengraben 29, 4051 Basel

Inventor

COATES, Professor Anthony

London Greater London SW17 0RE, GB

HU, Yanmin

London Greater London SW17 0RE, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.